Xeris Biopharma Inks Research Collaboration With Horizon Therapeutics To Develop Teprotumumab

Amgen, Horizon Therapeutics Reach Settlement On FTC Lawsuit; Seeks To Close Acquisition In Q4

Amgen (AMGN) and Horizon Therapeutics plc (HZNP) announced Friday the entry into a consent order agreement with the Federal Trade Commission (FTC) that resolves the pending FTC administrative lawsuit. This clears the path to take the final steps to close Amgen's $27.8 billion acquisition of Horizon.

RTTNews | 702 일 전

Horizon Says UPLIZNA Approved By Brazilian Health Regulatory Agency As Monotherapy For NMOSD

Biotechnology company Horizon Therapeutics plc (HZNP) announced Tuesday that the Brazilian Health Regulatory Agency (ANVISA) has approved UPLIZNA as a monotherapy for the treatment of adult patients with NMOSD who are AQP4-IgG+.

RTTNews | 957 일 전

Horizon Says Phase 2 Trial Of Dazodalibep To Treat Sjögren's Syndrome Met Primary Endpoint

Horizon Therapeutics plc (HZNP) announced Monday that its Phase 2 trial evaluating dazodalibep for the treatment of Sjögren's syndrome met the primary endpoint in patients with moderate-to-high systemic disease activity. Sjögren's syndrome is a disease with no FDA-approved treatments available.

RTTNews | 1056 일 전

Horizon Therapeutics To Buyback Up To $500 Mln Of Ordinary Shares

Biotechnology company Horizon Therapeutics plc (HZNP) today announced that its Board of Directors authorized the repurchase of up to $500 million of the Company's ordinary shares.

RTTNews | 1059 일 전

Malaysia Shares May Hand Back Friday's Gains

The Malaysia stock market has moved higher in two of three trading days since the end of the three-day losing streak in which it had fallen more than 15 points or 1 percent. The Kuala Lumpur Composite Index now sits just beneath the 1,535-point plateau although it may tick lower again on Monday.

RTTNews | 6 분 전

Japan Stock Market May Extend Friday's Losses

The Japan stock market headed south again on Friday, one day after ending the four-day losing streak in which it had given up almost 1,175 points or 2.8 percent. The Nikkei 225 now sits just shy of the 40,800-point plateau and it may open to the downside again on Monday.

RTTNews | 21 분 전

South Korea Shares May Extend Losing Streak

The South Korea stock market has moved lower in back-to-back sessions, tumbling more than 135 points or 3.9 percent along the way. The KOSPI now sits just shy of the 3,120-point plateau and it's likely to take further damage on Monday.

RTTNews | 36 분 전

Japan Monetary Base Data Due On Monday

Japan will on Monday release July figures for monetary base, highlighting a very light day for Asia-Pacific economic activity. In June, the base was down 3.3 percent on year.

RTTNews | 1 시간 36 분 전

EURUSD	1.15814	GBPUSD	1.3283	AUDUSD	0.64653
USDJPY	147.305	USDCAD	1.37822	USDCHF	0.80431

Advertisement

Xeris Biopharma Inks Research Collaboration With Horizon Therapeutics To Develop Teprotumumab